Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. Browse Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

1. Transparency Market
Research
Molecular Diagnostics Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast, 2013 – 2019
Molecular Diagnostics Market Expected to Reach USD 8.7 Billion
Globally in 2019: Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
122 Page ReportPublished Date
06-Feb-2014
Buy Now Request Sample
Press Release

2. Molecular Diagnostics Market
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth and Forecast,
2012 - 2019
Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular
biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular
level. This class of diagnostics tests is considered as the most well established and lucrative market in
the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to
requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost
per sample analysis, labor costs, improvements in automation and introduction of advanced
technologies have expanded the usage of molecular diagnostics tests. The growth of this market is
expected to surge due to various factors such as rise in incidence of hospital acquired infections,
increase in patient awareness along with growing elderly population. Additionally, outbreak of
diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the
growth of this market.
Browse Molecular Diagnostics Market Research Report with complete TOC at
http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
The research report on molecular diagnostics provides detailed analysis of the global market and
helps in understanding the driving forces responsible for its growth. The report discusses the
molecular diagnostics market on the basis of different technologies and applications. The technology
segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA),
hybridization technique, microarray, next generation sequencing and others. The application segment
is classified into infectious diseases, blood donor screening and genomics. The genomics segmented
is further classified into genetic disorders testing, oncology testing, HLA testing and pharmacogenetic
testing. The infectious diseases segment is subsegmented into virology and bacteriology. The virology
section of the report deals with testing of following infections namely, HIV (Human immunodeficiency
virus), HPV (Human papillomavirus), HCV (Hepatitis C virus) and others. The bacteriology segment of
the report is further categorized into hospital acquired infections (HAI), CT/NG (Chlamydia trachomatis
and Neisseria gonorrhoeae) and others. Market size estimates and forecasts for the period 2011 to
2019 have been provided for each of the segments in terms of USD million using 2012 as the base
year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided
along with market size estimations.
Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=1783
The molecular diagnostics market has also been segmented geographically into four regions: North
America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts
have been provided for each of these regions. A detailed qualitative analysis of the factors
Transparency Market Research
2
REPORT DESCRIPTION

3. Molecular Diagnostics Market
responsible for driving and restraining the growth of the global molecular diagnostics market, and
future opportunities has been provided in the market overview section. This section also features a
detailed market attractiveness analysis and Porter’s five forces analysis for the molecular diagnostics
market that would help in determining the degree of competition in the market. The entire section of
market overview plays an important role in understanding the market on a global level. Further, the
report on molecular diagnostics also provides executive summary that that will help you understand
the overall market size, growth rate of various segments, geographies and competitors present in the
market in a very precise manner.
Browse More Medical Devices Related Research Reports at
http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
The molecular diagnostics market report also provides a highlight of the competitive landscape of the
market wherein the market share analysis of the leading players in the market, in terms of
percentage share in 2012 has been discussed. A list of recommendations has also been included for
new entrants as well as existing market players to help them establish a strong presence in the
market and accentuate market shares. The report concludes with the profiles of major players in the
molecular diagnostics market such as Abbott Laboratories, Becton Dickinson & Company, Cepheid,
Roche Diagnostics and others. Profiles of these players have been extensively analyzed on the basis
of company overview, financial overview, business strategies, product portfolio and recent
developments.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
Chapter 2 Executive Summary
Transparency Market Research
3
TABLE OF CONTENT

4. Molecular Diagnostics Market
2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising incidence of cancer cases
3.2.2 Aging population
3.2.3 Increase in incidence of chronic diseases
3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines
3.3 Market Restraints
3.3.1 Issues with reimbursement policies
3.4 Market Opportunities
3.4.1 Technological advancements
3.4.2 Tapping the emerging economies
Browse Molecular Diagnostics Market Research Report with complete TOC at
http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
Transparency Market Research
4

5. Molecular Diagnostics Market
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography
Chapter 4 Molecular Diagnostics Market, by Technology
4.1 Overview
4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
4.2 Polymerase Chain Reaction (PCR)
4.2.1 Global PCR Market, 2011 – 2019 (USD Million)
4.3 Transcription Mediated Amplification (TMA)
4.3.1 Global TMA Market, 2011 – 2019 (USD Million)
4.4 Microarray
4.4.1 Global Microarray Market, 2011 – 2019 (USD Million)
4.5 Hybridization (ISH and FISH)
4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million)
4.6 Next-generation sequencing
4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Others Market, 2011 – 2019 (USD Million)
Chapter 5 Global Molecular Diagnostics Market, by Applications
Transparency Market Research
5

6. Molecular Diagnostics Market
5.1 Overview
5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Infectious Diseases
5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million)
5.2.2 Virology
5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million)
5.2.2.2 Human immunodeficiency virus (HIV) testing
5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million)
5.2.2.3 Human papillomavirus (HPV) testing
5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million)
5.2.2.4 Hepatitis C virus (HCV) testing
5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million)
5.2.2.5 Others
5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.2.3 Bacteriology
5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million)
5.2.3.2 Hospital Acquired Infection (HAI) testing
5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million)
5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing
5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million)
5.2.3.4 Others
5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million)
Transparency Market Research
6

7. Molecular Diagnostics Market
5.3 Genomics
5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million)
5.3.2 Genetic testing for inherited disorders
5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million)
5.3.3 Human Leukocyte Antigen (HLA)testing
5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million)
5.3.4 Pharmacogenetics testing
5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million)
Browse Molecular Diagnostics Market Research Report with complete TOC at
http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
5.3.5 Oncology testing
5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million)
5.4 Blood Donor Screening
5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million)
5.5 Others
5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
Chapter 6 Global Molecular Diagnostics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million)
Transparency Market Research
7

8. Molecular Diagnostics Market
6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
Chapter 7 Global Molecular Diagnostics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market
7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%)
7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market
Chapter 8 Recommendations
8.1 Market Strategies for Success
8.1.1 Long term contracts with healthcare service providers
Transparency Market Research
8

9. Molecular Diagnostics Market
8.1.2 Investing in emerging economies such as China, India and Russia
8.1.3 Broadening of distribution network
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Becton Dickinson & Company
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 bioMerieux
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
Transparency Market Research
9

10. Molecular Diagnostics Market
9.4 Bio-Rad
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
Browse Molecular Diagnostics Market Research Report with complete TOC at
http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
9.5 Cepheid
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Danaher Corporation (Beckman Coulter)
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
Transparency Market Research
10

11. Molecular Diagnostics Market
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Hologic, Inc. (Gen-Probe)
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Myriad Genetics, Inc.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Novartis International AG
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
Transparency Market Research
11

12. Molecular Diagnostics Market
9.10.4 Business Strategies
9.11 Qiagen
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Quest Diagnostics, Inc.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Siemens AG
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Thermo Fisher Scientific
9.14.1 Company Overview
9.14.2 Financial Overview
Transparency Market Research
12

13. Molecular Diagnostics Market
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-
looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Transparency Market Research
13
About Us
Contact